Join us for an overview and detailed analysis of the new Massachusetts pharmaceutical and medical device manufacturer conduct law as implemented by final regulations issued March 11, 2009. Compliance with the new law and regulations is required beginning July 1, 2009.
This law is the latest in a series of state laws regulating the sales and marketing practices of the pharmaceutical and/or medical device industry, and requires pharmaceutical and medical device manufacturers to:
- comply with a state marketing code of conduct (which includes certain requirements that are more restrictive than standards under the PhRMA Code or AdvaMed Code);
- undertake specific compliance activities (training, auditing and corrective action); and
- disclose payments to providers with a value of $50 or more in connection with broadly defined "sales and marketing activities."
Pharmaceutical and medical device manufacturers (and the Massachusetts health care providers with whom they interact) must understand the requirements and implications of the law as implemented, and take prompt action to ensure that their policies and practices are compliant. Our teleconference will outline the requirements, highlight open issues, compare requirements to industry codes as well as other state laws, and offer practical advice for implementing the requirements.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.